Content about Spasmodic torticollis

March 8, 2011

GREENSBORO, N.C. — Merz Pharmaceuticals has created two programs to provide financial assistance to patients using its drug for cervical dystonia, the company said Tuesday.

The programs — the Xeomin patient co-payment program and the Xeomin patient assistance program — cover Xeomin (incobotulinumtoxinA), designed to decrease the severity of abnormal head positions and neck pains in patients with the disease, which causes muscle contractions resulting in repetitive movements and abnormal postures.

August 16, 2010

US WorldMeds has acquired Solstice Neurosciences for $35.7 million, US WorldMeds said....

August 1, 2010

The Food and Drug Administration has approved a treatment for muscle spasms and twitches....

GREENSBORO, N.C. The Food and Drug Administration has approved a treatment for muscle spasms and twitches.